StockWatch
·
Pharmaceuticals
Corporate Governance22 Jul 2026, 08:10 pm

Biocon Director Bobby Kanubhai Parikh Completes Tenure

AI Summary

Biocon Ltd announced that Mr. Bobby Kanubhai Parikh, an Independent Director, has completed his second term and will cease to be a Director effective July 22, 2026. The Board of Directors expressed their appreciation for his contributions. This cessation is in accordance with SEBI Listing Regulations. Further details are provided in Annexure A, outlining his name, reason for cessation, and the effective date.

Key Highlights

  • Independent Director Bobby Kanubhai Parikh's tenure concludes on July 22, 2026.
  • The cessation is due to the completion of his second term as an Independent Director.
  • Biocon's Board acknowledges Mr. Parikh's contributions.
  • The event is a standard corporate governance procedure.